webleads-tracker

US Sunshine Act

Banning TV Drug Ads: Could the Cure Cause More Harm Than Good?

Direct-to-consumer (DTC) advertising in the U.S. of prescription drugs and medical devices is in the spotlight, with the American Medical Association (AMA) calling for a ban on it. The Chicago-based physicians group issued a statement last month that it has adopted a policy to block such advertising. The AMA’s chief argument is that the “growing proliferation of ads is driving demand for expensive treatments despite the clinical effectiveness of less costly alternatives.” Patrice A. Harris, chair-elect of the AMA, added: “Direct-to-consumer advertising also inflates demand for new and more expensive drugs, even when these drugs may not be appropriate.” The …

Read More »

Senate Finance Committee Hearing on Physician Owned Distributorships (PODs) Highlights the Complexity of the Issue

Transparence santé, Sunshine Act

November 20, 2015 by Thomas Sullivan The Senate Finance Committee has been conducting an investigation into Physician Owned Distributorships (PODs), leading to at least one referral to the Health and Human Services Office of Inspector General for potential action, the case of a device manufacturer who offered to make payments to doctors through a third party to avoid disclosure. To read the article by Policy & Medicine

Read More »

Open Payments: Research Payments Distorted by Including Value of the Medicines and Devices

Transparence santé, Sunshine Act

October 20, 2015. By Thomas Sullivan. The Open Payments program, an element of the Affordable Care Act (the « Sunshine Act »), has required the healthcare industry to adhere to a complex transparency program since its implementation in 2014. The Act is an attempt to track payments and transfers of value between life sciences manufacturers and healthcare professionals, and requires any payments and transfers of value to be reported publicly on the Open Payments website. Many have been concerned that such a requirement has the potential to do more harm than good, especially since the reliability of the data has been called …

Read More »

Bill Would Add Nurses, Physician Assistants to Pharma Payments Database

dollars for docs, sunshine act, transparency, compliance, loi bertrand, liens d'intérêts, transparence

Drugmakers disclose their payments to doctors, dentists, even chiropractors. But spending on nurse practitioners and physician assistants is excluded. Legislation in the Senate would change that. A bill proposed Wednesday by two U.S. senators would require drugmakers and medical device manufacturers to publicly disclose their payments to nurse practitioners and physician assistants for promotional talks, consulting, meals and other interactions. The legislation would close a loophole in the Physician Payment Sunshine Act, which requires companies to report such payments to doctors, dentists, chiropractors, optometrists and podiatrists. Companies have so far released more than 15 million payment records, covering August 2013 …

Read More »

Docs Still at Meetings Despite Sunshine Act

Since 2014, The Physician Open Payments program, commonly referred to as the Sunshine Act and now an element of The Affordable Care Act, has required the healthcare industry to adhere to a wide-ranging and complex transparency program to track the transfers of value between life sciences manufacturers and healthcare professionals, and to report these payments publicly on the Open Payments Web site. The regulation was put into place to raise public awareness of the financial relationships between HCPs and life sciences manufacturers, and reduce what some industry critics fear has been an undue influence by those organizations upon medical practitioners. …

Read More »